Pharmacology of BMN 250 administered via intracerebroventricular infusion once every 2 weeks for twenty-six weeks or longer in a canine model of mucopolysaccharidosis type IIIB
2018 ◽
Vol 123
(2)
◽
pp. S42
◽
2017 ◽
Vol 120
(1-2)
◽
pp. S44
◽
Keyword(s):
2014 ◽
Vol 111
(2)
◽
pp. S92
◽
Keyword(s):
2016 ◽
Vol 6
◽
pp. 41-47
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 41
(1)
◽
pp. 8-18
◽
2017 ◽
Vol 122
(1-2)
◽
pp. 100-106
◽
Keyword(s):